This company will be doing great soon, currently, it is undervalued too much.
The market cap is just 650K is unbelievable, Vivos (rdgl) has isopet for animal friends solid cancer treatment, it will generate revenue soon, and the animal treatment evidence work together generating strong preclinical effectiveness of this treatment for human clinical trials. All these will move this sticker much higher value. It should be valued at 100M or more.